A Cholesterol-Lowering Drug Reduces β-Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease

By Refolo L.M.   Pappolla M.A.   LaFrancois J.   Malester B.   Schmidt S.D.   Thomas-Bryant T.   Tint G.S.   Wang R.   Mercken M.   Petanceska S.S.   Duff K.E.  

Neurobiology of Disease, Vol. 8, Iss. 5, 2001-10 ,pp. : 890-899

Academic Press

Access to resources Recommend Favorite

Therapeutic Effects of Quetiapine on Memory Deficit and Brain &bgr;-Amyloid Plaque Pathology in a Transgenic Mouse Model of Alzheimer's Disease

By  

Current Alzheimer Research, Vol. 10, Iss. 3, 2013-03 ,pp. : 270-278

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of Trichostatin A on Gelsolin Levels, Proteolysis of Amyloid Precursor Protein, and Amyloid Beta-Protein Load in the Brain of Transgenic Mouse Model of Alzheimer's Disease

By  

Current Alzheimer Research, Vol. 11, Iss. 10, 2014-12 ,pp. : 1002-1011

Bentham Science Publishers

Access to resources Recommend Favorite

Intranasal NAP administration reduces accumulation of amyloid peptide and tau hyperphosphorylation in a transgenic mouse model of Alzheimer's disease at early pathological stage

By Matsuoka Yasuji   Gray Audrey   Hirata-Fukae Chiho   Minami S.   Waterhouse Emily   Mattson Mark   LaFerla Frank   Gozes Illana   Aisen Paul  

Journal of Molecular Neuroscience, Vol. 31, Iss. 2, 2007-06 ,pp. : 165-170

Humana Press, Inc

Access to resources Recommend Favorite

-Amyloid Plaques Induce Neuritic Dystrophy of Nitric Oxide-Producing Neurons in a Transgenic Mouse Model of Alzheimer's Disease

By Quinn J.   Davis F.   Woodward W.R.   Eckenstein F.  

Experimental Neurology, Vol. 168, Iss. 2, 2001-04 ,pp. : 203-212

Elsevier

Access to resources Recommend Favorite